Mechanisms of allergy and clinical immunologyDysregulation of type 2 innate lymphoid cells and TH2 cells impairs pollutant-induced allergic airway responses
Graphical abstract
Key words
Abbreviations used
Cited by (0)
Supported by the Interuniversity Attraction Poles Programme (IUAP), Belgian state; Belgian Science Policy (P7/30), Concerted Research Action of the Ghent University (BOF/GOA 01G02714); Fund for Scientific Research–Flanders (FWO-Vlaanderen); and Lung Foundation Netherlands (to R.W.H.). S.P. is a postdoctoral researcher of the Fund for Scientific Research–Flanders.
Disclosure of potential conflict of interest: R. W. Hendriks receives research support from the Lung Foundation, The Netherlands. A. N. J. McKenzie receives project funding form Janssen and MedImmune and receives royalties from Janssen. T. Maes receives travel support from GlaxoSmithKline and Boehringer Ingelheim. G. G. Brusselle serves as a board member for AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Novartis, and Sanofi and receives payment for lectures from AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Novartis, Pfizer, and Teva. G. F. Joos receives research funding from BelSPO and FWO Flanders; serves as a consultant for AstraZeneca, GlaxoSmithKline, and Novartis; and receives payments for lectures from AstraZeneca, GlaxoSmithKline, Novartis, SandozPharma, Novartis, and Sandoz Pharma and travel support from AstraZeneca and Novartis. The rest of the authors declare that they have no relevant conflicts of interest.
- ∗
These authors contributed equally to this work.
- ‡
These authors contributed equally to this work.